Comment from Medable Inc.
AnonymousSupportBusiness
Summary: Medable, Inc., a clinical trial technology company, expresses support for the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. They provide detailed technical recommendations on trial scope, participant selection, and evaluation metrics, while offering to participate as a technology partner.
Dear Dr. Mundkur and Members of the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program Coordination Team:
Medable, Inc. appreciates the opportunity to respond to the Agency’s Request for Information regarding the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. We participated in the May 15, 2026 Industry Information Session and have prepared these comments to align directly with the architectural and operational framing presented there. Please refer to the attached PDF file containing our full response to this RFI.
Thank you,
Medable, Inc.